|Salary:||£35,845 to £40,322 per annum|
|Placed On:||21st January 2020|
|Closes:||20th February 2020|
This post is available for up to 3 years to work on a Wellcome Trust Collaborative Award which draws together a consortium of laboratories across the world to define fundamental aspects of GPCR drug action with a particular focus on targeting muscarinic receptors in Alzheimer's disease. The researcher will be primarily located in Professor Andrew Tobin's laboratory at the University of Glasgow but will have the opportunity to travel and work at Monash University with Professors Arthur Christolopoulos and Patrick Sexton in Melbourne Australia as well as work within the collaborative network.
We are looking for a highly motivated individual with experience and interest in one or more of the following areas - biochemical and signalling pathways, molecular pharmacology, animal behavioural studies. The project will have a particular focus on applying the principles of GPCR-molecular pharmacology to the development of drugs that treat neurological disease particularly neurodegeneration and schizophrenia.
Candidates should have a PhD in a biological discipline and have published articles in international journals.
It is the University of Glasgow’s mission to foster an inclusive climate, which ensures equality in our working, learning, research and teaching environment.
We strongly endorse the principles of Athena SWAN, including a supportive and flexible working environment, with commitment from all levels of the organisation in promoting gender equity.
The University of Glasgow, charity number SC004401.
Type / Role: